您的位置: 首页 > 农业专利 > 详情页

FGFR/PD-1 COMBINATION THERAPY FOR THE TREATMENT OF CANCER
专利权人:
ASTEX THERAPEUTICS LIMITED
发明人:
LORENZI, Matthew V.,PLATERO, Suso Jesus,VERONA, Raluca,KARKERA, Jayaprakash
申请号:
SG11201708093V
公开号:
SG11201708093VA
申请日:
2016.04.01
申请国别(地区):
SG
年份:
2017
代理人:
摘要:
Provided herein are combination therapies for the treatment of cancer. In particular, the disclosed methods are directed to treatment of cancer in a patient comprising administering an antibody that blocks the interaction between PD-1 and PD-L1 and an FGFR inhibitor, wherein the antibody that blocks the interaction between PD-1 and PD-L1 and the FGFR inhibitor are administered if one or more FGFR variants are present in a biological sample from the patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充